Nottingham [England], November 22: The FDA on 10th November 2023 announced the approval of IXCHIQ®, Valneva's vaccine against the chikungunya virus. Notably, this is the first vaccine against the mosquito-borne disease to have been granted marketing approval by the FDA.
London [UK], February 1 (ANI/Sputnik): The United Kingdom secured on Monday 40 million extra doses of the Valneva COVID-19 vaccine candidate, taking to 100 million the total number of doses it has purchased from the French biotech company, the UK government announced.
London [UK], January 28 (ANI/Sputnik): Pharmaceutical firm Valneva has begun manufacturing its candidate vaccine against COVID-19 at a site in Scotland, the UK government said on Thursday.
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.